These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 12100186)

  • 1. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma.
    Meier F; Will S; Ellwanger U; Schlagenhauff B; Schittek B; Rassner G; Garbe C
    Br J Dermatol; 2002 Jul; 147(1):62-70. PubMed ID: 12100186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course and pattern of metastasis of cutaneous melanoma differ between men and women.
    Mervic L
    PLoS One; 2012; 7(3):e32955. PubMed ID: 22412958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study.
    Grözinger G; Mann S; Mehra T; Klumpp B; Grosse U; Nikolaou K; Garbe C; Clasen S
    Eur Radiol; 2016 Jun; 26(6):1826-34. PubMed ID: 26373757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
    Tas F; Erturk K
    Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease progression in patients with thin cutaneous melanomas (tumour thickness < or = 0.75 mm): clinical and epidemiological data from the Tumour Center Munich 1977-98.
    Schmid-Wendtner MH; Baumert J; Eberle J; Plewig G; Volkenandt M; Sander CA
    Br J Dermatol; 2003 Oct; 149(4):788-93. PubMed ID: 14616371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural course of cutaneous melanoma.
    Leiter U; Meier F; Schittek B; Garbe C
    J Surg Oncol; 2004 Jul; 86(4):172-8. PubMed ID: 15221923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of surgery on the course of melanoma.
    Lejeune FJ
    Recent Results Cancer Res; 2002; 160():151-7. PubMed ID: 12079209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma].
    Tejera-Vaquerizo A; Barrera-Vigo MV; Fernández-Canedo I; Blázquez-Sánchez N; Mendiola-Fernández M; Fernández-Orland A; Bosch-García R; de Troya-Martín M; Herrera-Ceballos E
    Actas Dermosifiliogr; 2007 Oct; 98(8):531-8. PubMed ID: 17919427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: results of a prospective multicenter study.
    Blum A; Schmid-Wendtner MH; Mauss-Kiefer V; Eberle JY; Kuchelmeister C; Dill-Müller D
    Dermatology; 2006; 212(1):47-52. PubMed ID: 16319474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
    Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
    Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline staging in cutaneous malignant melanoma.
    Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
    Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
    Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
    Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orderly progression of melanoma nodal metastases.
    Reintgen D; Cruse CW; Wells K; Berman C; Fenske N; Glass F; Schroer K; Heller R; Ross M; Lyman G
    Ann Surg; 1994 Dec; 220(6):759-67. PubMed ID: 7986143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
    Monroe MM; Pattisapu P; Myers JN; Kupferman ME
    Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma.
    Meyer T; Merkel S; Göhl J; Hohenberger W
    Eur J Surg Oncol; 2002 Jun; 28(4):424-30. PubMed ID: 12099654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional cutaneous metastasis in patients with therapeutic lymph node dissection for malignant melanoma: risk factors and prognostic impact.
    Kretschmer L; Preusser KP; Neumann C
    Melanoma Res; 2002 Oct; 12(5):499-504. PubMed ID: 12394192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with melanoma and histologically negative sentinel lymph nodes: one institution's experience.
    De Giorgi V; Leporatti G; Massi D; Lo Russo G; Sestini S; Dini M; Lotti T
    Oncology; 2007; 73(5-6):401-6. PubMed ID: 18515980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.